<?xml version="1.0" encoding="UTF-8"?><CAS version="2"><uima.cas.Sofa _indexed="0" _id="1" sofaNum="1" sofaID="_InitialView" mimeType="text" sofaString="P09473483A0953 It may also be suggested that particular care should be taken when such a trans-dominant Rev mutant is considered to be used as a genetic therapy against HIV-I infection, in individuals infected with both HIV-I and HTLV-1."/><uima.tcas.DocumentAnnotation _indexed="1" _id="8" _ref_sofa="1" begin="0" end="237" language="x-unspecified"/><edu.cmu.tanl.type.gene _indexed="1" _id="13" _ref_sofa="1" begin="66" end="82" Gene="dominant Rev mutant"/><edu.cmu.tanl.type.gene _indexed="1" _id="18" _ref_sofa="1" begin="171" end="175" Gene="HIV-I"/><edu.cmu.tanl.type.gene _indexed="1" _id="23" _ref_sofa="1" begin="179" end="184" Gene="HTLV-1"/></CAS>